CPI-637 is primarily used in research settings to study its potential therapeutic effects, particularly in the field of oncology. It functions as a selective inhibitor of certain enzymes involved in gene regulation, making it a valuable tool for understanding cellular processes and disease mechanisms. Researchers are exploring its efficacy in targeting specific pathways associated with cancer progression, with the aim of developing novel treatments. Additionally, CPI-637 is utilized in preclinical studies to assess its impact on tumor growth and survival, providing insights into its potential as a future anticancer agent. Its application extends to biochemical assays and drug discovery efforts, where it helps identify new therapeutic targets and optimize drug candidates.